Deals

Neptune Technologies & Bioressources Raises $2.3M at 9% Premium via Euro Pacific Canada

By |

Neptune Technologies & Bioressources Inc. (NEPT) announced that it has raised $2,267,500 in a Common Stock transaction. The common stock was sold at $2.50 per share, an approximate 9% premium to the market price ($2.29) of NEPT at deal announcement. Euro Pacific Canada, Inc. acted as the exclusive agent on the transaction. The investor was Fiera Capital QSSP II Investment Fund Inc. . via PlacementTracker.

Deals

Venaxis Closes $20M CMPO via Cannaccord, Craig-Hallum

By |

Venaxis Inc (APPY) announced that it has raised $20,004,000 in a CMPO/Overnight transaction. The common stock was sold at $2.40 per share, an approximate 11% discount to the market price ($2.71) of APPY at deal announcement. Canaccord Genuity Inc. acted as Sole Book-Runner with Craig-Hallum Capital Group LLC as Lead Manager on the transaction. Underwriter counsel was Goodwin Procter, LLP and issuer counsel was Ballard Spahr LLP. The transaction is expected to close on 04/08/2014.

Deals

Cytomedix Raises $9M in Conv Debt at 89% Discount from Deerfield Management

By |

Cytomedix, Inc. (CMXI) announced that it has raised $9,000,000 in a Convertible Senior Secured Debentures transaction. The Notes are convertible at the lesser of $0.057 per share, an approximate 88.6% discount to the market price ($0.50) of CMXI at deal announcement and 93% of the last sale on the Date of Closing. BTIG, LLC acted as Placement Agent and the investor was Deerfield Management Company. Note that this Placement funded in two tranches. The first tranche of $9,000,000 funded on 3/31/2014 and the second tranche of $26,000,000 will fund upon shareholder approval.

Deals

Cytomedix Raises $2M at Slight Premium from Anson Capital

By |

Cytomedix, Inc. CMXI announced that it has raised $2,000,000 in a Common Stock transaction. The common stock was sold at $0.52 per share, an approximate 4% premium to the market price $0.50 of CMXI at deal announcement. A series of 2,884,615 60-Month Warrants with an exercise price of $0.52 per share 4% premium was issued to the investors in this transaction. BTIG, LLC acted as the exclusive agent on the transaction and the investor was Anson Capital.This Placement is part of a $11 million financing. The other $9 million was funded in the form of Convertible Notes.